TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Bloomberg TVs' Doolittle Breaks Down Nasdaq Biotech Movers
OPINION

3 biotech stocks under $10 to trade for big gains.

  • By Roberto Pedone
  • Jan 15, 2016 6:37 AM EST
Here's Why Chesapeake Energy Isn't Coming Back
OPINION

5 Stocks Under $10 Set to Soar: Must-See Charts

  • By Christopher Sahl
  • Dec 24, 2015 8:49 AM EST
4 Stocks Under $10 Making Big Moves Higher
OPINION

4 Stocks Under $10 Making Big Moves Higher

  • By Roberto Pedone
  • Sep 15, 2015 1:58 PM EDT
Immunotherapy Stocks Power Higher on Celgene-Juno Deal
OPINION

3 Breakout Biotech Stocks Trading for Under $10

  • By Roberto Pedone
  • Sep 1, 2015 2:57 PM EDT
4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Jul 24, 2014 2:55 PM EDT
5 Biotech Stocks to Trade for Breakouts
INVESTING

5 Biotech Stocks to Trade for Breakouts

  • By Roberto Pedone
  • Feb 24, 2014 2:08 PM EST
5 Stocks Under $10 Set to Soar
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Jan 2, 2014 1:11 PM EST
Uncertainty Remaining in Boston Scientific
OPINION

Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets

  • By Chris Katje
  • Dec 27, 2013 11:03 AM EST
AbbVie Deserves More Respect
STOCKS

Biodel Fails to Excite Investors With Me-Too Mealtime Insulin

  • By Adam Feuerstein
  • Sep 9, 2013 10:14 AM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

5 Stocks Ready to Break Out

  • By Roberto Pedone
  • Aug 23, 2013 3:36 PM EDT
Biotech's Next Big Thing: Fall Trials
VIDEO

Biotech's Next Big Thing: Fall Trials

  • By Adam Feuerstein
  • Aug 23, 2013 5:00 AM EDT
5 Hated Earnings Stocks You Should Love
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Jul 18, 2013 12:17 PM EDT
3 Unusual-Volue Stocks on the Rise
INVESTING

4 Biotech Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • Jul 17, 2013 6:42 AM EDT
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Understanding a Coin-Flip Game Can Make You a Smarter Biotech Investor

  • By David Sobek
  • Jun 26, 2013 9:24 AM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

3 Health Care Stocks Under $10 to Watch

  • By Roberto Pedone
  • Jun 18, 2013 2:39 PM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: 2013 Clinical Trials Calendar

  • By Adam Feuerstein
  • Jun 7, 2013 7:00 AM EDT
Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

The Run-Up Trade: Biodel's Insulin Trial Results

  • By Mark Messier
  • May 30, 2013 8:00 AM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Biodel's CEO Discusses F3Q12 Results - Earnings Call Transcript

  • By Seeking Alpha
  • Aug 10, 2012 6:18 PM EDT
4 Huge Stocks on Traders' Radars
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Feb 9, 2012 2:15 PM EST
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed
STOCKS

Targacept Trial Tragedy Takeaway: Don't Trust Clinical Data From India

  • By Adam Feuerstein
  • Nov 8, 2011 12:39 PM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Borders, Corinithian: Small-Cap Winners

  • By Shanthi Bharatwaj
  • Jan 14, 2011 12:31 PM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Wave Systems, Biodel: Small-Cap Winners

  • By Shanthi Bharatwaj
  • Jan 13, 2011 12:37 PM EST
Must-See Charts of the Week
INVESTING

Ivy League Investing With the Yale Endowment

  • By Jonas Elmerraji
  • Nov 10, 2010 7:50 AM EST
FDA to Review Amgen Drugs: BioBuzz
STOCKS

Biotech Sector Weekly Rewind

  • By Adam Feuerstein
  • Nov 6, 2010 9:14 AM EDT
Vertex Cures Hard-to-Treat Hep C Patients
STOCKS

The Top FDA Drug Approval Pickers

  • By Adam Feuerstein
  • Nov 5, 2010 11:41 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.